IVBXF

Innovent Biologics Inc/ADR

Healthcare · Biotechnology

$249.59 sample

+3.74 (+1.52%) 1D

Market cap

$1.49T

Price as of

2026-10-03

Latest filing

8-K · 2026-09-29

Alerts

8

Price$249.59 -0.47% 3M daily closessample

254.51231.29

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29SEC8-K filed: material event
Sep 23SECDEF 14A filed
Sep 16INSInsider sell: General Counsel
Sep 07INSInsider buy: Chief Financial Officer
Sep 01INSInsider sell: Director
Aug 27INSInsider sell: Director
Aug 19SECForm 144 filed
Aug 12SEC8-K filed: material event

Sign up to see the real IVBXF record →

Company facts

SEC EDGAR registration

Name: Innovent Biologics Inc/ADR
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +23sample, -100 to +100
Reporting currency: USD

Who is positioning in IVBXF

sample

Insiders: 29 insider transactions over 90 days, net selling, $304.0M
Congress: No member trades over 90 days
Institutions · 13F: 13 funds hold $15.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$74.8B +24.3% y/y

Q4 2024Q3 2026

Inventory$43.5B +17.7% y/y

Q4 2024Q3 2026

Accounts receivable$32.1B +9.1% y/y

Q4 2024Q3 2026

Total debt$84.7B +15.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $824.6B -12.1% 3M
Sample peer B: $674.8B +13.6% 3M
Sample peer C: $569.6B -11.5% 3M
Sample peer D: $313.2B +8.1% 3M
Sample peer E: $1.18T +15.1% 3M